Rocket Lab SEC Filings

This Schedule 13D/A (Amendment No. 10) removes Khosla Ventures V and Associates V as reporting persons after pro rata distributions of all shares by Dec 8, 2025. VK Services, LLC and Vinod Khosla now beneficially own 34,888,272 shares (6.5%). Investors note continued passive stake by prominent VC without activist intent.

Jon A. Olson, Director of Rocket Lab USA Inc., sold 15,205 shares of common stock on January 20, 2026, across multiple transactions at weighted-average prices ranging from $89.02 to $97.92, totaling approximately $1.39 million. The sales were automatic under a Rule 10b5-1 trading plan adopted on September 19, 2025. This represents a neutral signal due to the pre-planned nature.

Rocket Lab disclosed a rupture in the Neutron rocket's Stage 1 tank during hydrostatic pressure qualification testing. The incident was announced via press release on January 21, 2026. The company is analyzing test data to determine effects on the Neutron launch schedule; no financial impacts were quantified.

Rocket Lab Director Merline Saintil disposed of 96,000 shares via exchange fund contribution at $86.58 and sold 12,500 shares at $90 pursuant to a 10b5-1 plan. Total disposition: 108,500 shares worth ~$9.4M, reducing holdings to 280,029 shares. Neutral signal due to planned 10b5-1 execution and diversification move.

This Form 144 discloses director Merline A. Saintil's intent to sell 12,500 common shares acquired via RSUs in 2023, valued at $1,082,250. She sold 35,000 shares totaling ~$2.05M in Dec 2025 under a 10b5-1 plan adopted Sep 17, 2025. Relevant to investors as routine insider selling with certification of no undisclosed adverse info.

Frank Klein, Chief Operations Officer of Rocket Lab USA, sold 100,000 shares on 01/02/2026 at prices ranging $67.61-$75.80, totaling ~$7.3M. The sales were automatic under a Rule 10b5-1 plan adopted 09/19/2025. Neutral signal due to pre-scheduled nature.

Adam C. Spice, Rocket Lab's CFO, exercised 731,330 employee stock options at $1.09 and sold 1,365,665 common shares across multiple transactions at weighted-average prices from $72.15 to $78.04, totaling ~$103M. The sales were automatic under a Rule 10b5-1 plan adopted September 19, 2025. This is a neutral signal.

This Form 144 filing notifies of COO Adam C. Spice's proposed sale of 1,365,665 common shares, valued at $103.8M, on or about January 5, 2026. Shares stem from stock option exercises on Jan 5, 2026 (731,330 shares) and Sep 18, 2025 (634,335 shares). The sale follows a Rule 10b5-1 plan adopted Sep 19, 2025; Spice reports prior 3-month sales of 62,627 shares for $2.55M. Relevant for investors tracking insider activity.

This Form 144 filing notifies of officer Frank Klein's proposed sale of 100,000 common shares acquired from RSU vesting. The sale, valued at $6.98M, is under a Rule 10b5-1 plan adopted 9/19/2025, with approximate date 1/2/2026. In past 3 months, Klein sold ~51k shares for ~$2.1M; routine liquidity for investors.

Edward H. Frank, Director at Rocket Lab USA (RKLB), gifted 5,000 shares and sold 2,500 shares on 12/23/2025. Sale at $77.39/share totals ~$193K, reducing holdings to 142,504 shares. Neutral gift with moderate bearish discretionary sale signal.